Cited by 791Cardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmiasCardiovascular Effects of Exercise

The DOI matches its Crossref record, with a small difference in title or year; 171 of the 172 references it cites were found in a registry or an index.

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

Open access

McNally, Elizabeth M., Mestroni, Luisa·2017·Circulation Research

DOI 10.1161/circresaha.116.309396PMC PMC5626020

Open this paper in CoChat — free account

Abstract

Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of the large number of genes and alleles attributed to DCM, comprehensive genetic testing encompasses ever-increasing gene panels. Genetic diagnosis can help predict prognosis, especially with regard to arrhythmia risk for certain subtypes. Moreover, cascade genetic testing in family members can identify those who are at risk or with early stage disease, offering the opportunity for early intervention. This review will address diagnosis and management of DCM, including the role of genetic evaluation. We will also overview distinct genetic pathways linked to DCM and their pathogenetic mechanisms. Historically, cardiac morphology has been used to classify cardiomyopathy subtypes. Determining genetic variants is emerging as an additional adjunct to help further refine subtypes of DCM, especially where arrhythmia risk is increased, and ultimately contribute to clinical management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.116.309396

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,671
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citation

Show all 172 references

Research works printed but not linked: 2

10.1172/JCI19670 · DOI
MacRae C, Taylor MRG, Mestroni L, Moses JR, Ashley EA, Wheeler MT, Lakdawala NK, Hershberger RE, Ptaszynski M, Sandor V, Saunders ME, Oliver C, Lee PA, Judge DP. Phase 2 study of a797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin a/c-related dilated cardiomyopathy. Eur Heart J. 2016;37:1011.

Sorted by citations

Items 401–500 of 791

Role of the electrocardiogram in differentiating genetically determined dilated cardiomyopathy from athlete's heart
Zaffalon, D., Papatheodorou, E., Merghani, A., Dhutia, H., Moccia, E., Malhotra, A., Miles, C. J., Attard, V., Homfray, T., Sharma, R. K., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13837 · Cited by 7
Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities
Gui, L.-K., Liu, H.-J., Jin, L., & Peng, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1342173 · Cited by 6
The Impact of Cardio-Renal-Metabolic Profile in Dilated Cardiomyopathy
Akbari, T., Hammersley, D. J., May, C. Y.-Y., Halliday, B. P., & Prasad, S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02241-8 · Cited by 6
Sarcomeric remodelling in human heart failure unraveled by single molecule long read sequencing
Haas, J., Schudy, S., Rauscher, B., Verdú, A. M., Roßkopf, S., Reich, C., Dönmez, G., Yalcin, A., Seeger, T., Dieterich, C., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00370-9 · Cited by 6
A novel causative functional mutation in GATA6 gene is responsible for familial dilated cardiomyopathy as supported by in silico functional analysis
Khazamipour, A., Gholampour‐Faroji, N., Zeraati, T., Vakilian, F., Haddad‐Mashadrizeh, A., Ghayour‐Mobarhan, M., & Pasdar, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-13993-6 · Cited by 6
Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy
Lau, C. W. Z., Gul, U. J., Liu, B., Captur, G., & Hothi, S. S. (2023) · Medicina · doi:10.3390/medicina59030439 · Cited by 6
The application of radiology for dilated cardiomyopathy diagnosis, treatment, and prognosis prediction: a bibliometric analysis
Fang, Q., Huang, K., Yao, X., Peng, Y., Kan, A., Song, Y., Wang, X., Xiao, X., & Gong, L. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-34 · Cited by 6
Variable clinical expression of a novel FLNC truncating variant in a large family
Tomer, O., Cederboim, S. H., Rivkin, D., Meiner, V., Gollob, M. H., Zwas, D. R., Durst, R. Y., & Shauer, A. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.131849 · Cited by 6
Machine Learning in Identifying Marker Genes for Congenital Heart Diseases of Different Cardiac Cell Types
Ma, Q., Zhang, Y., Guo, W., Feng, K., Huang, T., & Cai, Y. (2024) · Life · doi:10.3390/life14081032 · Cited by 6
Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunction
Iwanski, J. B., Pappas, C. T., Mayfield, R. M., Farman, G. P., Ahrens‐Nicklas, R. C., Churko, J. M., & Gregorio, C. C. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00366-y · Cited by 6
The ‘Padua classification’ of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic
Corrado, D., Graziano, F., Bauce, B., Marinas, M. B., Calore, C., Celeghin, R., Cipriani, A., Gaspari, M. D., Lazzari, M. D., Migliore, F., et al. (2025) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suae108 · Cited by 6
Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers
Mahmoud, B., Cox, M. G. P. J., de Brouwer, R., van der Heide, M. Y. C., Gorter, T. M., Meems, L. M. G., Wilde, A. A. M., van Veldhuisen, D. J., de Boer, R. A., & Westenbrink, B. D. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf118 · Cited by 6
The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy
Wang, W., Gao, Y., Lee, H. K., Yu, A. C., Kipp, M., Kaddatz, H., & Zhan, J. (2025) · Cells · doi:10.3390/cells14110778 · Cited by 7
Expression Levels of miR-146b and Anti-Cardiac Troponin I in Serum of Children with Viral Myocarditis and Their Clinical Significance
Yan, M., Jing, W. A. N. G., Suyun, W. A. N. G., Zhang, Y., Liu, L., & Zhao, H. (2021) · Iranian Journal of Public Health · doi:10.18502/ijph.v50i3.5592 · Cited by 6
MicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease
Amodio, F., Caiazza, M., Fimiani, F., Calabrò, P., & Limongelli, G. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11040023 · Cited by 6
Clonal Haematopoiesis of Indeterminate Potential-Related Mutations and Outcome in Dilated and Ischaemic Cardiomyopathy
Wu, J. M. F., Bekfani, T., Hinze, A., Westphal, J. G., Steinacker, B., Zeller, M., Hartmann, C., Möbius‐Winkler, S., Hochhaus, A., Schulze, P. C., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14115 · Cited by 6
Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis
Guo, Q., Qu, Q., Wang, L., Liao, S., Zhu, X., Du, A., Zhu, Q., Cheang, I., Gao, R., & Li, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2708246 · Cited by 6
Functional assays reveal the pathogenic mechanism of a de novo tropomyosin variant identified in patient with dilated cardiomyopathy
Barrick, S. K., Garg, A., Greenberg, L., Zhang, S., Lin, C., Stitziel, N. O., & Greenberg, M. J. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.01.014 · Cited by 6
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Cardiovascular Disease: A Comprehensive Clinical Review on Dilated Cardiomyopathy
Ganipineni, V. D. P., Gutlapalli, S. D., Danda, S., Garlapati, S. K. P., Fabián, D., Okorie, I. J., & Paramsothy, J. (2023) · Cureus · doi:10.7759/cureus.35774 · Cited by 6
Construction and evaluation of immune-related diagnostic model in patients with heart failure caused by idiopathic dilated cardiomyopathy
Xu, S., Wu, Z., & Chen, H. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03666-1 · Cited by 6
Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies
Serpa, F., Finn, C. M., & Tahir, U. A. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10405-x · Cited by 6
Personalized Medicine in Inflammatory Cardiomyopathy
Neupane, B., Zhou, Q., Gawaz, M., & Gramlich, M. (2018) · Personalized Medicine · doi:10.2217/pme-2017-0074 · Cited by 6
Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective
Chen, K., Song, J., Wang, Z., Rao, M., Chen, L., & Hu, S. (2018) · Clinical Cardiology · doi:10.1002/clc.22906 · Cited by 6
What May the Future Hold for Sports Cardiology?
Gerche, A. L., Baggish, A. L., Heidbüchel, H., Levine, B. D., & Rakhit, D. J. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.05.193 · Cited by 6
Associations Between TAB2 Gene Polymorphisms and Dilated Cardiomyopathy in A Chinese Population
Shen, C., Zhong, Y., Huang, X., Wang, Y., Peng, Y., Li, K., Zhou, B., Zhang, L., & Rao, L. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0384 · Cited by 6
Epigenetic reprogramming to prevent genetic cardiomyopathy
Johnston, J. R., Selgrade, D. F., & McNally, E. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143684 · Cited by 6
Self-citation
Pathology of sudden death, cardiac arrhythmias, and conduction system
Thiene, G., Rizzo, S., & Basso, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00007-4 · Cited by 6
Nonclinical Cardiovascular Assessment of the Soluble Guanylate Cyclase Stimulator Vericiguat
Himmel, H. M., Lagrutta, A., Vömel, M., Amin, R. P., Imredy, J. P., Johnson, T. J., Vinzing, M., Prescott, J. S., & Blaustein, R. O. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001368 · Cited by 6
Assessment of right ventricular function in advanced heart failure with nonischemic dilated cardiomyopathy: insights of right ventricular elastance
Bianco, F., Bucciarelli, V., Ammirati, E., Occhi, L., Musca, F., Tonti, G., Frigerio, M., & Gallina, S. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000921 · Cited by 6
Prevalence and trends of occult coronary artery disease in patients with dilated cardiomyopathy.
Chandra, S., Saraf, S., Chaudhary, G. K., Dwivedi, S. K., Narain, V. S., Sethi, R., SHARMA, A. K., Pradhan, A. K., Vishwakarma, P., & Bhandari, M. (2020) · Europe PMC (PubMed Central) · Cited by 6
The Frequency, Penetrance and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank ParticipantsPreprint
Shah, R. A., Asatryan, B., Dabbagh, G. S., Aung, N., Khanji, M. Y., Lopes, L. R., van Duijvenboden, S., Holmes, A. M., Muser, D., Landstrom, A. P., et al. (2021) · medRxiv · doi:10.1101/2021.11.22.21266651 · Cited by 6
Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy
Hunter, B., Zhang, Y., Harney, D., McEwen, H. P., Koay, Y. C., Pan, M., Malecki, C., Khor, J. X. Y., Hume, R. D., Guglielmi, G., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00281-9 · Cited by 5
Enhancing cardiac serine biosynthesis mitigates the progression of dilated cardiomyopathy in mice
Kay, M., Samuelsson, A., Bharucha, N., Li, X., Ramchandani, R., Baum, R. E., Arvizo, D. R., Laguerre, A., Lajevardi, S., Kambhampati, S., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156395 · Cited by 5
Non-Ischemic Late Iodine Enhancement on Cardiac Computed Tomography ― Prevalence and Prognostic Significance ―
Oguni, T., Izumiya, Y., Takashio, S., Kuyama, N., Tabata, N., Hanatani, S., Usuku, H., Matsuzawa, Y., Kidoh, M., Oda, S., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0599 · Cited by 5
iPSCs for modeling of sarcomeric cardiomyopathies
Poetsch, M. S., & Guan, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822227-0.00012-0 · Cited by 6
Genetic background determines the severity of age-dependent cardiac structural abnormalities and arrhythmia susceptibility in Scn5a-1798insD mice
Marchal, G. A., Rivaud, M. R., Wolswinkel, R., Basso, C., van Veen, T. A. B., Bezzina, C. R., & Remme, C. A. (2024) · EP Europace · doi:10.1093/europace/euae153 · Cited by 5
Downregulation of miR-214 promotes dilated Cardiomyopathy Progression through PDE5A-Mediated cGMP regulation
Yan, J., Wang, X., Cao, P., Li, Q., & Wu, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-78983-2 · Cited by 5
Regulation of TTN as a mechanism of and treatment for heart failure
Fullenkamp, D. E. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189335 · Cited by 5
CT and MR Imaging of Cardiomyopathies in Clinical Practice–An Approach After an Abnormal Echocardiogram or Electrocardiogram
Monteiro, P. F., Peixoto, T., Rodrigues, P., & Carvalho, J. G. (2025) · Echocardiography · doi:10.1111/echo.70104 · Cited by 5
Dilated Cardiomyopathy May Be Associated With a Novel Mitochondrial tRNASer(AGY) Mutation
Ding, Y., Yu, X., Xu, J., Zhang, S., & Leng, J. (2025) · Human Mutation · doi:10.1155/humu/7888334 · Cited by 5
Investigating Ganglion Cell Complex Thickness in Children with Chronic Heart Failure due to Dilated Cardiomyopathy
Rakusiewicz, K., Kanigowska, K., Hautz, W., & Ziółkowska, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092882 · Cited by 5
Progress and Research Priorities in Imaging Genomics for Heart and Lung Disease: Summary of an NHLBI Workshop
Nayor, M. G., Shen, L., Hunninghake, G. M., Kochunov, P., Barr, R. G., Bluemke, D. A., Broeckel, U., Caravan, P. D., Cheng, S. C., de Vries, P. S., et al. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.012943 · Cited by 5
Self-citation
Comparison of and Frequency of Mortality, Left Ventricular Assist Device Implantation, Ventricular Arrhythmias, and Heart Transplantation in Patients With Familial Versus Nonfamilial Idiopathic Dilated Cardiomyopathy
Rao, R. A., Kozaily, E., Jawaid, O., Sabra, M., El-Am, E. A., Chaaya, R. G. B., Woiewodski, L., Elsemesmani, H., Ramchandani, J., Shah, C. D., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.06.018 · Cited by 5
The genetic basis for adult-onset idiopathic dilated cardiomyopathy in people of African descent
Tsabedze, N., Ramsay, M., Krause, A., Wells, Q. S., Mpanya, D., & Manga, P. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10302-9 · Cited by 5
Feasibility of the Omaha system for the care of children with dilated cardiomyopathy
Zhang, Q., Zhang, A., Wang, Y., Lv, T., Sun, P., Zhao, X., Li, R., & Zheng, X. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1136663 · Cited by 5
Can Right Ventricular Endomyocardial Biopsy Predict Left Ventricular Fibrosis Beforehand in Dilated Cardiomyopathy?
Amemiya, K., Matsuyama, T., Ishibashi‐Ueda, H., Morita, Y., Matsumoto, M., Ohta‐Ogo, K., Ikeda, Y., Tsukamoto, Y., Fukushima, N., Fukushima, S., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14642 · Cited by 5
Sex-based differences in the phenotypic expression and prognosis of idiopathic non-ischaemic cardiomyopathy: a cardiovascular magnetic resonance study
Mallabone, M., Labib, D., Abdelhaleem, A., Dykstra, S., Thompson, R. B., Paterson, D. I., Thompson, S. K., Hasanzadeh, F., Mikami, Y., Rivest, S. M., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae014 · Cited by 5
Gene-expression profiling of endomyocardial biopsies from dogs with dilated cardiomyopathy phenotype
Loria, A. D., Ferravante, C., D’Agostino, Y., Giurato, G., Tursi, M., Grego, E., Perego, M., Weisz, A., Ciaramella, P., & Santilli, R. A. (2024) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2024.02.008 · Cited by 5
TTN novel splice variant in familial dilated cardiomyopathy and splice variants review: a case report
León-Goméz, P., Franco, P., Hinojosa, N., Torres, K., Moreano, A., & Romero, V. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1387063 · Cited by 5
Homozygous TNNI3 frameshift variant in a consanguineous family with lethal infantile dilated cardiomyopathy
Kraoua, L., Louati, A., Ahmed, S. B., Abida, N., Khémiri, M., Menif, K., Mrad, R., Zaffran, S., & Jaouadi, H. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2486 · Cited by 5
Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy
Murphy, M. R., Ganapathi, M., Rotlevi, E. R., Lee, T. M., Fisher, J. M., Patel, M. V., Jayakar, P., Buchanan, A., Rippert, A. L., Ahrens‐Nicklas, R. C., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00761-8 · Cited by 5
Association Between AXIN1 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Han Population
Li, K., Zhong, Y., Peng, Y., Zhou, B., Wang, Y., Li, Q., Zhang, Y., Song, H., & Rao, L. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4567 · Cited by 5
Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy
Ito, M., Nomura, S., Morita, H., & Komuro, I. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00154 · Cited by 6
Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy
Bazrafshan, S., Kushlaf, H. A., Kakroo, M. A., Quinlan, J. G., Becker, R. C., & Sadayappan, S. (2021) · Cells · doi:10.3390/cells10020349 · Cited by 5
Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study
Chen, X., Han, H.-F., He, Z., & Xu, X.-G. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2252832 · Cited by 5
A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies
Sharma, R., Kaur, N., Kushwah, A. S., Singh, N., & Thakur, S. (2022) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x23666230123122808 · Cited by 5
Sport activity in patients with cardiomyopathies: a review
Andreini, D., Bauce, B., Limongelli, G., Monosilio, S., Lorenzo, F. D., Angelini, F., Melotti, E., Monda, E., Mango, R., Toso, E., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001470 · Cited by 5
Clinical Characteristics, Cardiac Magnetic Resonance Features, and Outcomes of Patients with Dilated Cardiomyopathy – An Experience from a South Asian Country
Shams, P., & Sultan, F. A. T. (2021) · Journal of Clinical Imaging Science · doi:10.25259/jcis_126_2021 · Cited by 5
Integrated machine learning and multimodal data fusion for patho-phenotypic feature recognition in iPSC models of dilated cardiomyopathy
Wali, R., Xu, H., Cheruiyot, C., Saleem, H. N., Janshoff, A., Habeck, M., & Ebert, A. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0023 · Cited by 4
Multimodal Mapping of Electrical and Mechanical Latency of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Layers
Zhang, X., Burattini, M., Duru, J., Chala, N., Wyssen, N., Cofiño‐Fabrés, C., Rivera‐Arbeláez, J. M., Passier, R. C., Dimos Poulikakos, A., Ferrari, A., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c03896 · Cited by 4
Genotype-phenotype insights of pediatric dilated cardiomyopathy
Dai, Y., Wang, Y., Fan, Y., & Han, B. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1505830 · Cited by 4
Region- and Cell-type–Resolved Multiomic Atlas of the Heart
Zhang, F., Wang, Y., Zhu, J., Wang, J., Li, Q., Feng, J., Liu, M., Li, K., Tan, J., Luo, R., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100922 · Cited by 4
Revisiting Secondary Dilative Cardiomyopathy
Kundnani, N. R., Luca, F. D., Meche, V., Sharma, A., Popa, M.-D., Nicula, M., Voinescu, O. R., Iacob, M. S., Duda-Seiman, D., & Dragan, S. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094181 · Cited by 4
Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target
Ma, L., Lu, B., Si, Y., Dai, L., Tan, M., Liu, W., Sun, D., Shu, J., Chen, C., Xiang, Q., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110421 · Cited by 5
Clinical and metabolic consequences of a historic pathogenic lamin A/C founder variant
Wong, L. Y., Torfs, T., Vanherle, S. J. V., Janssen, J. W. H., Claes, G. R. F., Stroeks, S. L. V. M., Willemars, M. M. A., Schianchi, F., Kapsokalyvas, D., Weltjens, E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08495-0 · Cited by 4
Sudden Death in Children and Young Adults: Etiologies, Risk Stratification, and Prevention Strategies
Ahmad, R., Arslan, F. S., Niaz, M., Khan, S., Hussain, S. S., Kumar, M., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001043 · Cited by 4
Metabolomics in cardiovascular diseases: from prevention strategies to domain-specific applications
Zhao, Q., Pang, Y. Y., Lim, R. L., Tham, W. K., & Choi, H. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2606050 · Cited by 5
Phenotypes and mechanisms of dysfunctional cardiac T-lymphocytes in dilated cardiomyopathy patients
Angelotti, A., Ponnusamy, T., Kumar, D. V., Passarelli, G. V., Malysz, J., Mahesh, B., Soleimani, B., Bradley, E. A., & Bansal, S. S. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.12.011 · Cited by 4
RBM20 variants disrupt Ca2+ handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models
Rebs, S., Sedaghat‐Hamedani, F., Kayvanpour, E., Eberl, H., Berečić, B., Dudek, J., Wagensohner, N., Seedorf, A., Unsöld, J. K., Hübscher, D., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02838-7 · Cited by 4
The Impact of Atorvastatin on Cardiac Performance for Dilated Cardiomyopathy: A Meta-analysis of Randomized Controlled Studies
Фу, Л., Shang, X., & Zhang, X. (2020) · The Heart Surgery Forum · doi:10.1532/hsf.2787 · Cited by 4
Neuromuscular and cardiovascular phenotypes in paediatric titinopathies: a multisite retrospective study
Meyer, A. P., Barnett, C. L., Myers, K., Siskind, C. E., Moscarello, T., Logan, R., Roggenbuck, J., & Rich, K. A. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109513 · Cited by 4
Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy
Ankudavičė, K. M. , Šukys, M., Kasputytė, G., Krikštolaitis, R., Ereminienė, E., Galnaitienė, G., Mizarienė, V., Šakalytė, G., Krilavičius, T., & Jurkevičius, R. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03888-x · Cited by 4
In silico and in vitro models reveal the molecular mechanisms of hypocontractility caused by TPM1 M8R
Creso, J. G., Gokhan, I., Rynkiewicz, M. J., Lehman, W., Moore, J. R., & Campbell, S. G. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1452509 · Cited by 4
Precision medicine applications in dilated cardiomyopathy: Advancing personalized care
Khattab, E., Myrianthefs, M. M., Sakellaropoulos, S., Alexandrou, K., & Mitsis, A. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103076 · Cited by 4
Stroke in Dilated Cardiomyopathy: An Autopsy-Based Study of Mechanisms, Topography, and Clinical Implications
Țica, O., Sabau, M., Venter, A. C., Beiușanu, C., Berechet, M. C., Huniadi, A. C., Şandor, M. I., & Ţică, O. (2025) · Diagnostics · doi:10.3390/diagnostics15182287 · Cited by 4
Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
Baman, J. R., Patil, K. D., Medhekar, A. N., & Wilcox, J. E. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.02.006 · Cited by 4
Whole-Exome Sequencing Identified a Novel Variant (C.405_422+39del) in DSP Gene in an Iranian Pedigree with Familial Dilated Cardiomyopathy
Eshaghkhani, Y., Mohamadifar, A., Asadollahi, M., Taghizadeh, M., Karamzade, A., Saberi, M., Nourmohammadi, P., Golchehre, Z., Amin, A., & Keramatipour, M. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.10.2.280 · Cited by 4
Social Inequalities in Non-ischemic Cardiomyopathies
Amiya, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831918 · Cited by 4
Sporadic dilated cardiomyopathy is often familial
Marian, A. J. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac075 · Cited by 4
Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy
Luo, K., Zheng, C., Luo, R., Cao, X., Sun, H., Ma, H., Huang, J., Yang, X., Wu, X., & Li, X. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01349-y · Cited by 4
Inherited cardiomyopathies: how nurses can facilitate holistic care for patients and their families
Martin, L., Mason, S., Kirkby, C., Kearl, F., Hargrave, J., Partridge, J., Taylor, J. S., Bueser, T. ‘., & Cowley, B. (2023) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2022.0107 · Cited by 4
Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A)
Djemai, M., Jauvin, D., Poulin, H., Chapotte-Baldacci, C.-A., & Chahine, M. (2024) · Stem Cell Research · doi:10.1016/j.scr.2024.103308 · Cited by 4
Targeting ERBB2 and PIK3R1 as a therapeutic strategy for dilated cardiomyopathy: A single-cell sequencing and mendelian randomization analysis
He, B., Quan, L.-P., Li, C., Yan, W., Zhang, Z., Zhou, L., Wei, Q., Li, Z., Mo, J., Zhang, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25572 · Cited by 4
Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review
Raimondi, L., Raimondi, F. M., Rossi, L., Lazzeroni, R., Pietranera, M., Benedetto, L. D., Gozzi, E., & Spinelli, G. P. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155220982044 · Cited by 4
Association between CDK8 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population
Zhang, R., Zhong, Y., Long, S.-Y., Yang, Q.-N., Zhou, B., & Rao, L. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-21-323 · Cited by 4
Personalizing treatments for patients based on cardiovascular phenotyping
Leopold, J. A. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2022.2028548 · Cited by 4
Clinical Characteristics of Heart Failure with Reduced Ejection Fraction Patients with Rare Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes: A Subgroup Analysis of the PARADIGM-HF Trial
Barat, A., Chen, C., Patel-Murray, N. L., McMurray, J. J. V., Packer, M., Solomon, S. D., Desai, A. S., Rouleau, J. L., Zile, M. R., Attari, Z., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2886 · Cited by 4
Different substitutions at the same β-myosin residue underlie divergent molecular phenotypes and distinct cardiomyopathies
Lehman, S. J., Meller, A., Solieva, S. O., Lotthammer, J. M., Greenberg, L., Langer, S. J., Greenberg, M. J., Tardiff, J. C., Bowman, G. R., & Leinwand, L. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113585 · Cited by 4
Whole-exome sequencing reveals doubly novel heterozygous Myosin Binding Protein C and Titin mutations in a Chinese patient with severe dilated cardiomyopathy
Fan, L., Chen, Y., Huang, H., Jin, J., Li, J., & Tan, Z. (2018) · Cardiology in the Young · doi:10.1017/s1047951118001403 · Cited by 4
Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group
SANT'ANNA, R. T., Eibel, B., Markoski, M. M., Rodrigues, C. G., de Salles, F. B., Giusti, I. I., Nesralla, I. A., Nardi, N. B., & Kalil, R. A. K. (2019) · Gene Therapy · doi:10.1038/s41434-019-0087-2 · Cited by 4
Predicting Arrhythmia Risk in Dilated Cardiomyopathy Using Genetic Mutation Status
McNally, E. M., & Amaral, A. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.034 · Cited by 4
Self-citation
Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
Sun, Y., Xiao, L., Li, K., Wang, H., Song, X., Li, Z., Li, C., Chen, Y., Li, S., Huang, J., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752662 · Cited by 3
Decoding mitochondrial stress genes in DCM: towards precision diagnosis and therapy
Zhu, B., Cheng, H., Li, J., Hu, Y., & Ge, X. (2025) · Hereditas · doi:10.1186/s41065-025-00399-3 · Cited by 3
Shared splicing dysregulation in heart failure associated with dilated and ischaemic cardiomyopathy and spatial specificity across cardiac regions
Furtado, M., Barbosa, P., Wemans, A., Zhang, L., Lumley, A. I., Carvalho, T., Napoleão, P., Leszek, P., Carmo‐Fonseca, M., Devaux, Y., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag068 · Cited by 3
Prevalence of deleterious variants in cardiomyopathy genes in early-onset atrial fibrillation
Vad, O. B., Vilaseca, Q. B., Beyer, A. F., Paludan‐Müller, C., Andreasen, L., Svendsen, J. H., & Lundegaard, P. R. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02119-5 · Cited by 3
Cardiac disorders
Bhatia, A. K., Tenney, T. B., & Bryksin, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00028-7 · Cited by 3
Severe cardiac conduction disease associated with titin gene mutation
Uniat, J., Hill, A. C., Shwayder, M. H., & Bar‐Cohen, Y. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14726 · Cited by 3
Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions
Couto, J., & Martins, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144706 · Cited by 3
Heart Physiology and Heart Disease
Okwose, N. C., Charman, S. J., Fuller, A. S., MacGowan, G., Filipović, N., & Jakovljević, D. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-60044-9_3 · Cited by 4
Three Novel Pathogenic Variants in Unrelated Vietnamese Patients with Cardiomyopathy
Tran, D. D., Lien, N. T. K., Tung, N. V., Hựu, N. C., Nguyen, P. T., Tien, D. A., Thu, D. T. H., Huy, B. Q., Oanh, T. T. K., Lien, N. T. P., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14232709 · Cited by 3

Authors: McNally, E. M., & Mestroni, L.
Affiliations: Northwestern University (US)
ORCID: McNally, Elizabeth M.
Mestroni, Luisa
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2017-09-15
Volume: 121
Issue: 7
Pages: 731-748
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.116.309396
PMC: PMC5626020
OpenAlex: W2755193453
Cited by: 786
References: 172
Citations by year: 2026: 63 · 2025: 89 · 2024: 93 · 2023: 123 · 2022: 89 · 2021: 105 · 2020: 95 · 2019: 79 · 2018: 43 · 2017: 4
FWCI: 8.52
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (UL1TR001422, UL1TR001082)
National Heart, Lung, and Blood Institute (R01HL122109, R01HL116906, R01HL147064, R01HL128075, R01HL061322, R01HL069071)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: dilated cardiomyopathy, non-ischemic cardiomyopathy, genetic testing, gene panel, cascade testing, arrhythmia risk, prognosis, genetic variants, pathophysiological mechanisms, cardiac morphology, early intervention
MeSH terms: Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks